PNC
48
6
BMY
40
-5
CI
35
2
DOW
47
4
MMM
35
3
NTRS
35
10
DLTR
52
8
ZTS
38
4
PNR
56
2
AAP
26
5
GD
42
4
PHM
44
4
PDCO
77
3
DHI
36
3
LUV
45
3
CA
19
6
MRK
25
2
HAL
40
11
CHD
34
7
NDAQ
46
2
PNC
48
6
BMY
40
-5
CI
35
2
DOW
47
4
MMM
35
3
NTRS
35
10
DLTR
52
8
ZTS
38
4
PNR
56
2
AAP
26
5
GD
42
4
PHM
44
4
PDCO
77
3
DHI
36
3
LUV
45
3
CA
19
6
MRK
25
2
HAL
40
11
CHD
34
7
NDAQ
46
2
Financhill
Back

Intellia Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
5

NTLA
Intellia Therapeutics

Last Price:
$12.20
Seasonality Move:
-3.92%
Sell
42

REGN
Regeneron Pharmaceuticals

Last Price:
$701.91
Seasonality Move:
10.8%
Sell
5
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $12.21. The Score for NTLA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $701.85. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $12.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight buying pressure.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $701.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 34.7 Sell
Chaikin Money Flow: 734391 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13 - 14.98) Sell
Bollinger Bands (100): (14.92 - 22.24) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -29.66 Sell
Relative Strength Index (14 RSI): 27.8 Sell
Chaikin Money Flow: -1643849 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (727.49 - 769.33) Sell
Bollinger Bands (100): (805.13 - 1140.25) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.92 Sell
20-day SMA: 14.03 Sell
50-day SMA: 15.6 Sell
200-day SMA: 21.65 Sell
8-day EMA: 12.86 Sell
20-day EMA: 13.76 Sell
50-day EMA: 15.52 Sell
200-day EMA: 21.32 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 729.36 Sell
20-day SMA: 747.95 Sell
50-day SMA: 826.21 Sell
200-day SMA: 980.92 Sell
8-day EMA: 726.23 Sell
20-day EMA: 750.86 Sell
50-day EMA: 823.81 Sell
200-day EMA: 934.41 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.19 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and a decrease next year of $0.01 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):